| scholarly article | Q13442814 |
| P2093 | author name string | Ming Lei | |
| James A Fraser | |||
| Yanmin Zhang | |||
| Christopher L-H Huang | |||
| Andrew A Grace | |||
| Kamalan Jeevaratnam | |||
| Sandeep S Hothi | |||
| Xiaojin Hao | |||
| P2860 | cites work | Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia | Q78390804 |
| Expanding spectrum of human RYR2-related disease: new electrocardiographic, structural, and genetic features | Q24294249 | ||
| KCNQ1 gain-of-function mutation in familial atrial fibrillation | Q24338486 | ||
| Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death | Q24674590 | ||
| Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia | Q28142708 | ||
| Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia | Q28201561 | ||
| A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel | Q28204838 | ||
| Catecholaminergic polymorphic ventricular tachycardia | Q28287523 | ||
| Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2+ leak promotes atrial fibrillation in mice | Q30488460 | ||
| Arrhythmic disorder mapped to chromosome 1q42-q43 causes malignant polymorphic ventricular tachycardia in structurally normal hearts | Q33145152 | ||
| Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. | Q33147854 | ||
| Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor. | Q33152686 | ||
| Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients | Q33173888 | ||
| Acute atrial arrhythmogenesis in murine hearts following enhanced extracellular Ca(2+) entry depends on intracellular Ca(2+) stores. | Q33514742 | ||
| Pharmacological changes in cellular Ca2+ homeostasis parallel initiation of atrial arrhythmogenesis in murine Langendorff-perfused hearts. | Q33739827 | ||
| Protection from cardiac arrhythmia through ryanodine receptor-stabilizing protein calstabin2. | Q34312242 | ||
| Calstabin deficiency, ryanodine receptors, and sudden cardiac death | Q35874314 | ||
| Mechanisms of atrial remodeling and clinical relevance. | Q35982796 | ||
| Mechanisms of atrial fibrillation: lessons from animal models. | Q36272316 | ||
| Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutation | Q36999467 | ||
| Physiological consequences of the P2328S mutation in the ryanodine receptor (RyR2) gene in genetically modified murine hearts | Q37066411 | ||
| Atrial arrhythmogenesis in wild-type and Scn5a+/delta murine hearts modelling LQT3 syndrome | Q37214708 | ||
| Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. | Q37268790 | ||
| Cardiac gene defects can cause sudden cardiac death in young people | Q37535546 | ||
| Atrial remodeling and atrial fibrillation: mechanisms and implications. | Q37609710 | ||
| Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. | Q43073409 | ||
| Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target | Q43270475 | ||
| Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice | Q43773122 | ||
| Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia | Q46981935 | ||
| Measurement of heart rate and Q-T interval in the conscious mouse. | Q50898283 | ||
| Familial polymorphic ventricular arrhythmias: a quarter century of successful medical treatment based on serial exercise-pharmacologic testing | Q73250272 | ||
| P433 | issue | 4 | |
| P304 | page(s) | 794-804 | |
| P577 | publication date | 2010-07-09 | |
| P1433 | published in | Cardiovascular Research | Q4642329 |
| P1476 | title | Acute atrial arrhythmogenicity and altered Ca(2+) homeostasis in murine RyR2-P2328S hearts | |
| P478 | volume | 89 |
| Q36952000 | Abnormal Ca(2+) homeostasis, atrial arrhythmogenesis, and sinus node dysfunction in murine hearts modeling RyR2 modification |
| Q48287484 | Age-dependent electrocardiographic changes in Pgc-1β deficient murine hearts. |
| Q38039083 | An introduction to murine models of atrial fibrillation |
| Q54440604 | Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts. |
| Q47099943 | Effects of ageing on pro-arrhythmic ventricular phenotypes in incrementally paced murine Pgc-1β -/- hearts |
| Q41910718 | Flecainide exerts paradoxical effects on sodium currents and atrial arrhythmia in murine RyR2-P2328S hearts. |
| Q58616505 | Gene and Protein Expression Profile of Selected Molecular Targets Mediating Electrophysiological Function in Deficient Murine Atria |
| Q64265892 | Identification of RyR2-PBmice and the effects of transposon insertional mutagenesis of the RyR2 gene on cardiac function in mice |
| Q35295864 | Imaging atrial arrhythmic intracellular calcium in intact heart |
| Q96576958 | Intracellular calcium leak in heart failure and atrial fibrillation: a unifying mechanism and therapeutic target |
| Q50490336 | Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation. |
| Q41458404 | Mitochondrial oxidative stress promotes atrial fibrillation |
| Q39038606 | Murine Electrophysiological Models of Cardiac Arrhythmogenesis |
| Q47136909 | Pro-arrhythmic atrial phenotypes in incrementally paced murine Pgc1β-/- hearts: effects of age. |
| Q51591524 | Slowed depolarization and irregular repolarization in catecholaminergic polymorphic ventricular tachycardia: a study from cellular Ca2+ transients and action potentials to clinical monophasic action potentials and electrocardiography. |
| Q36688514 | The RyR2-P2328S mutation downregulates Nav1.5 producing arrhythmic substrate in murine ventricles. |
| Q35215931 | The involvement of TRPC3 channels in sinoatrial arrhythmias |
Search more.